Media coverage
1Media coverage
Title US FDA Approves Expanded Use of Bristol-Myers Squibb's Daklinza (daclatasvir) for Additional Challenging-to-Treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C Media name/outlet India Pharma News Country India Date 2/5/16 Persons Fred Poordad